These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1644876)

  • 1. Aplastic anemia: the role of immunosuppression.
    Billett HH
    Hosp Pract (Off Ed); 1992 Aug; 27(8):35, 39-40, 43 passim. PubMed ID: 1644876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
    Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
    Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of aplastic anaemia.
    Gordon-Smith EC
    Br J Haematol; 1983 Feb; 53(2):185-8. PubMed ID: 6336948
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
    Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
    Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison between ALG and bone marrow transplantation in treatment of severe aplastic anemia.
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Würsch A; Tichelli A; Lori A; Reusser P; Jeannet M; Signer E
    Thymus; 1987; 10(1-2):147-58. PubMed ID: 3324403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the diagnosis and management of acquired aplastic anaemia.
    Marsh JC; Ball SE; Darbyshire P; Gordon-Smith EC; Keidan AJ; Martin A; McCann SR; Mercieca J; Oscier D; Roques AW; Yin JA;
    Br J Haematol; 2003 Dec; 123(5):782-801. PubMed ID: 14632769
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-thymocyte globulin treatment for aplastic anemia.
    Jansen J; Zwaan FE; Haak HL; te Velde J; Guiot HF; Sabbe LJ; Eernisse JG; Tricot GJ; van Rood JJ
    Scand J Haematol; 1982 Apr; 28(4):341-51. PubMed ID: 7051265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe fatigue: could it be aplastic anemia?
    Afable MG; Lyon DE
    Clin J Oncol Nurs; 2008 Aug; 12(4):569-73. PubMed ID: 18676324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppression, bone marrow infusion and low dose androgens, successful therapy of severe aplastic anemia].
    Cornu P; Speck B; Gratwohl A; Nissen C; Sartorius J; Jeannet M
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1384-5. PubMed ID: 384511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antilymphocyte globulin as the sole immunosuppressant for bone marrow transplantation in aplastic anemia. A case report.
    Rogentine GN; Rosenberg EB; Merritt CB; Rosenberg SA; Yankee RA; Graw RG; Greipp P; Whang-Peng J; Fahey JL
    Transplantation; 1973 May; 15(5):514-7. PubMed ID: 4575740
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent progress in the diagnosis and treatment of aplastic anemia in children].
    Kojima S
    Rinsho Ketsueki; 2009 Oct; 50(10):1444-52. PubMed ID: 19915353
    [No Abstract]   [Full Text] [Related]  

  • 12. Late graft rejection following allogeneic bone marrow transplantation in aplastic anemia.
    Rodriguez V; Khan SP
    Transplant Proc; 2002 Jun; 34(4):1307-9. PubMed ID: 12072347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of severe aplastic anemia (SAA) by bone marrow transplantation (BMT) or immunosuppression?].
    Höcker P; Hinterberger W; Gadner H; Hajek-Rosenmayr A; Fischer-Hinterberger M; Kos M; Emminger W; Panzer S; Lechner K
    Beitr Infusionther Klin Ernahr; 1987; 18():329-31. PubMed ID: 3326592
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
    Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
    Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modern management of severe aplastic anaemia.
    Ball SE
    Br J Haematol; 2000 Jul; 110(1):41-53. PubMed ID: 10930978
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].
    Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM
    Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive treatment of aplastic anemia as an alternative treatment for bone marrow transplantation.
    Gluckman E; Marmont A; Speck B; Gordon-Smith EC
    Semin Hematol; 1984 Jan; 21(1):11-9. PubMed ID: 6367052
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithymocyte globulin: a realistic approach to therapy for severe aplastic anemia.
    Hunter RF; Huang AT
    South Med J; 1986 Sep; 79(9):1121-5. PubMed ID: 3529435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aplastic anemia. Alternative treatment by bone marrow transplantation].
    Fonseca T; Raposo J; Gomez B; d'Oliveira JJ; de Lacerda JM
    Acta Med Port; 1997 Jan; 10(1):99-102. PubMed ID: 9245186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aplastic anemia].
    Klingemann HG; Havemann K
    Dtsch Med Wochenschr; 1984 Nov; 109(47):1816-21. PubMed ID: 6389074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.